Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Expert Review of Anticancer Therapy|April 29, 2024
Establishing biomarkers for soft tissue sarcomasAnna M Czarnecka, Paulina Chmiel, Piotr Błoński, et al.
Expert Opinion on Biological Therapy|December 15, 2016
Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agentsCamillo Porta, Ilaria Toscani, Anna M Czarnecka, et al.
BMC Cancer|July 14, 2016
Insulin-like growth factor-1 signaling in renal cell carcinomaAdam F Tracz, Cezary Szczylik, Camillo Porta, et al.
Journal of Cell Communication and Signaling|April 1, 2019
Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulatorsWojciech Solarek, Michal Koper, Slawomir Lewicki, et al.
International Journal of Molecular Medicine|October 18, 2016
Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literatureDominika Labochka, Barbara Moszczuk, Wojciech Kukwa, et al.
Future Oncology (London, England)|August 12, 2015
Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experienceAnna M Czarnecka, Maciej Kawecki, Fei Lian, et al.
Future Oncology (London, England)|December 20, 2014
Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancerAnna M Czarnecka, Wojciech Kukwa, Anna Kornakiewicz, et al.
Urologic Oncology|August 23, 2015
Interleukin-6 as an emerging regulator of renal cell cancerKatarzyna Kamińska, Anna M Czarnecka, Bernard Escudier, et al.
Pageof 17